Radiopharmaceuticals pluvicto / lutathera
Ended Awarded Last action
- Contract number
- 36C25026N0254
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $316,160
Award facts
- Contract value 100% obligated
- $316,159.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- East Hanover, NJ 07936, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 10 (VISN 10) awarded a $316,159.88 firm fixed-price delivery order to Novartis Pharmaceuticals Corporation for radiopharmaceuticals, specifically PLUVICTO and LUTATHERA, with a completion date of January 31, 2026. This delivery order was issued without a small business set-aside and is placed against Novartis' existing Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The contractor, headquartered in East Hanover, New Jersey, is a foreign-owned pharmaceutical manufacturer specializing in cancer therapies and nuclear medicine products for federal healthcare systems.
This award is issued as a task order under Novartis' larger Blanket Purchase Agreement valued at $7.48 million with VISN 10 through September 30, 2030, which is dedicated to procuring PLUVICTO for the VA's integrated service network. These radiopharmaceuticals represent specialized medical treatments utilized in cancer therapy programs across the VA system, supporting the administration's commitment to delivering advanced oncology care to the veteran population. The delivery order structure enables efficient procurement of these critical pharmaceutical products through the established General Services Administration schedule vehicle.
Quick answers
Who was awarded contract 36C25026N0254?
36C25026N0254 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 1, 2026.
How much is contract 36C25026N0254 worth?
The government has obligated $316,160 on 36C25026N0254.
Is contract 36C25026N0254 an order under another contract?
Yes. 36C25026N0254 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25026N0254 competed?
The extent of competition for 36C25026N0254 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award